These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 12077496)
1. Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy. Deng L; Xu G Drugs; 2023 Apr; 83(6):507-530. PubMed ID: 37017915 [TBL] [Abstract][Full Text] [Related]
2. Predictive prognostic value of glomerular C3 deposition in IgA nephropathy. Xie M; Zhu Y; Wang X; Ren J; Guo H; Huang B; Wang S; Wang P; Liu Y; Liu Y; Zhang J J Nephrol; 2023 Mar; 36(2):495-505. PubMed ID: 35781866 [TBL] [Abstract][Full Text] [Related]
3. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients. Lammerts RGM; Eisenga MF; Alyami M; Daha MR; Seelen MA; Pol RA; van den Born J; Sanders JS; Bakker SJL; Berger SP Front Immunol; 2019; 10():2511. PubMed ID: 31736953 [TBL] [Abstract][Full Text] [Related]
4. The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy? Michels MAHM; Volokhina EB; van de Kar NCAJ; van den Heuvel LPWJ Pediatr Nephrol; 2019 Aug; 34(8):1349-1367. PubMed ID: 30141176 [TBL] [Abstract][Full Text] [Related]
5. Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease. Zaferani A; Vivès RR; van der Pol P; Hakvoort JJ; Navis GJ; van Goor H; Daha MR; Lortat-Jacob H; Seelen MA; van den Born J J Biol Chem; 2011 Feb; 286(7):5359-67. PubMed ID: 21135110 [TBL] [Abstract][Full Text] [Related]
6. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. Abbate M; Zoja C; Corna D; Rottoli D; Zanchi C; Azzollini N; Tomasoni S; Berlingeri S; Noris M; Morigi M; Remuzzi G J Am Soc Nephrol; 2008 Jun; 19(6):1158-67. PubMed ID: 18354030 [TBL] [Abstract][Full Text] [Related]
7. Chronic interstitial damage in proteinuria. Does complement mediate tubulointerstitial injury? Sheerin NS; Sacks SH Kidney Blood Press Res; 1999; 22(1-2):47-52. PubMed ID: 10352407 [TBL] [Abstract][Full Text] [Related]
8. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. Eddy AA J Am Soc Nephrol; 1994 Dec; 5(6):1273-87. PubMed ID: 7893992 [TBL] [Abstract][Full Text] [Related]
9. Proteinuria as a mediator of tubulointerstitial injury. Abbate M; Remuzzi G Kidney Blood Press Res; 1999; 22(1-2):37-46. PubMed ID: 10352406 [TBL] [Abstract][Full Text] [Related]
10. Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors? Hsu SI; Couser WG J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S186-91. PubMed ID: 12819326 [TBL] [Abstract][Full Text] [Related]
12. Role of complement in tubulointerstitial injury from proteinuria. Tang S; Lai KN; Sacks SH Kidney Blood Press Res; 2002; 25(2):120-6. PubMed ID: 12077496 [TBL] [Abstract][Full Text] [Related]